Advertisement

Index by Author

August 1998; 47 (8)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Al-Barazanji, K A

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  2. Alcazar, O

    • Lactate production in pancreatic islets. Diabetes August 1998 47:1219-1223; doi:10.2337/diabetes.47.8.1219

  3. Al Rayyes, O

    • Troglitazone upregulates LDL receptor activity in HepG2 cells. Diabetes August 1998 47:1193-1198; doi:10.2337/diabetes.47.8.1193

  4. Arnold, R

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  5. Ashcroft, S J

    • Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1. Diabetes August 1998 47:1274-1280; doi:10.2337/diabetes.47.8.1274

  6. Ashfield, R

    • Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1. Diabetes August 1998 47:1274-1280; doi:10.2337/diabetes.47.8.1274

B

  1. Baqué, S

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

  2. Basmaciogullari, A

    • Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes August 1998 47:1236-1242; doi:10.2337/diabetes.47.8.1236

  3. Bass, K E

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311

  4. Bell, G I

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354
    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  5. Benoist, C

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  6. Bergner, E A

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  7. Bond, B

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  8. Brocco, S

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  9. Bruttomesso, D

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  10. Buchanan, T A

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  11. Buckingham, R E

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  12. Bush, D M

    • Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes August 1998 47:1335-1340; doi:10.2337/diabetes.47.8.1335

  13. Byrne, M M

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

C

  1. Caballero, S

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311
    • Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes August 1998 47:1335-1340; doi:10.2337/diabetes.47.8.1335

  2. Camps, M

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

  3. Clapham, J C

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  4. Clausen, J O

    • The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians. Diabetes August 1998 47:1359-1361

  5. Connor, S C

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  6. Cummings, E A

    • Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes August 1998 47:1341-1346; doi:10.2337/diabetes.47.8.1341

  7. Czernichow, P

    • Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes August 1998 47:1236-1242; doi:10.2337/diabetes.47.8.1236

D

  1. Daneman, D

    • Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes August 1998 47:1341-1346; doi:10.2337/diabetes.47.8.1341

  2. Davis, E M

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  3. Dekker, M G

    • Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes August 1998 47:1341-1346; doi:10.2337/diabetes.47.8.1341

  4. Del Prato, S

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  5. Demuth, H U

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

E

  1. Eiberg, H

    • The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians. Diabetes August 1998 47:1359-1361

F

  1. Florén, C H

    • Troglitazone upregulates LDL receptor activity in HepG2 cells. Diabetes August 1998 47:1193-1198; doi:10.2337/diabetes.47.8.1193

  2. Flurkey, K

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

  3. Furuta, H

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

G

  1. Galardy, R E

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311

  2. German, M S

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  3. Gilon, P

    • Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells. Diabetes August 1998 47:1266-1273; doi:10.2337/diabetes.47.8.1266

  4. Giné, E

    • Lactate production in pancreatic islets. Diabetes August 1998 47:1219-1223; doi:10.2337/diabetes.47.8.1219

  5. Girardi, C

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  6. Gliem, K

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  7. Göke, B

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  8. Gómez-Foix, A M

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

  9. Gonzalez, A

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  10. Goodyear, L J

    • Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes August 1998 47:1369-1373; doi:10.2337/diabetes.47.8.1369

  11. Gordon, E J

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  12. Grant, M B

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311
    • Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes August 1998 47:1335-1340; doi:10.2337/diabetes.47.8.1335

  13. Greiner, D L

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  14. Guinovart, J J

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

  15. Gylfe, E

    • In situ characterization of nonmitochondrial Ca2+ stores in individual pancreatic beta-cells. Diabetes August 1998 47:1224-1230; doi:10.2337/diabetes.47.8.1224

H

  1. Hagman, C

    • In situ characterization of nonmitochondrial Ca2+ stores in individual pancreatic beta-cells. Diabetes August 1998 47:1224-1230; doi:10.2337/diabetes.47.8.1224

  2. Hanafusa, T

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  3. Haneda, M

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  4. Hansen, T

    • The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians. Diabetes August 1998 47:1359-1361

  5. Hara, M

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  6. Haskins, K

    • Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes August 1998 47:1212-1218; doi:10.2337/diabetes.47.8.1212

  7. Hayashi, T

    • Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes August 1998 47:1369-1373; doi:10.2337/diabetes.47.8.1369

  8. Hellman, B

    • In situ characterization of nonmitochondrial Ca2+ stores in individual pancreatic beta-cells. Diabetes August 1998 47:1224-1230; doi:10.2337/diabetes.47.8.1224

  9. Henquin, J C

    • Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells. Diabetes August 1998 47:1266-1273; doi:10.2337/diabetes.47.8.1266

  10. Henriksson, J

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  11. Herberg, L

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

  12. Hidaka, H

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  13. Hirshman, M F

    • Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes August 1998 47:1369-1373; doi:10.2337/diabetes.47.8.1369

  14. Höglund, P

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  15. Horiike, K

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  16. Horikawa, Y

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354
    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

I

  1. Idahl, L A

    • Lactate production in pancreatic islets. Diabetes August 1998 47:1219-1223; doi:10.2337/diabetes.47.8.1219

  2. Iwahashi, H

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  3. Iwamoto, Y

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  4. Iwasaki, N

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

J

  1. Jackson, R

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  2. Jiang, X J

    • Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes August 1998 47:1281-1286; doi:10.2337/diabetes.47.8.1281

  3. Jonas, J C

    • Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic beta-cells. Diabetes August 1998 47:1266-1273; doi:10.2337/diabetes.47.8.1266

  4. Jori, E

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  5. Junger, E

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

K

  1. Kashiwagi, A

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  2. Katschinski, M

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  3. Katz, J D

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  4. Kikkawa, R

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  5. Kjos, S L

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  6. Kocova, M

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  7. Kohama, T

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  8. Kojima, H

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  9. Krook, A

    • Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes August 1998 47:1281-1286; doi:10.2337/diabetes.47.8.1281

  10. Kurth, E J

    • Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes August 1998 47:1369-1373; doi:10.2337/diabetes.47.8.1369

  11. Kwok, W W

    • Molecular basis for HLA-DQ associations with IDDM. Diabetes August 1998 47:1177-1184; doi:10.2337/diabetes.47.8.1177

L

  1. Lawson, M L

    • Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes August 1998 47:1341-1346; doi:10.2337/diabetes.47.8.1341

  2. Le Beau, M M

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  3. Le Bras, S

    • Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes August 1998 47:1236-1242; doi:10.2337/diabetes.47.8.1236

  4. Lee, W P

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  5. Leiter, E H

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

  6. Lind, L

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  7. Lithell, H

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  8. Ljubimov, A V

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311

M

  1. Maegawa, H

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  2. Maeno, Y

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  3. Markees, T G

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  4. Martin, T

    • Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes August 1998 47:1212-1218; doi:10.2337/diabetes.47.8.1212

  5. Mathis, D

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  6. Matsuzawa, Y

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  7. Mazzon, C

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  8. McIntosh, C H

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

  9. Millgård, J

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  10. Miralles, F

    • Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes August 1998 47:1236-1242; doi:10.2337/diabetes.47.8.1236

  11. Miyagawa, J

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  12. Miyazaki, J

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  13. Montell, E

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

  14. Mordes, J P

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

N

  1. Nader, I

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  2. Nakajima, H

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  3. Namba, M

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  4. Nepom, G T

    • Molecular basis for HLA-DQ associations with IDDM. Diabetes August 1998 47:1177-1184; doi:10.2337/diabetes.47.8.1177

  5. Niesler, C U

    • Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes August 1998 47:1365-1368; doi:10.2337/diabetes.47.8.1365

  6. Nishigori, H

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  7. Nishio, Y

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  8. Noelle, R J

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  9. Noguchi, T

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

O

  1. O'Rahilly, S

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  2. Ogata, M

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

  3. Okita, K

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

P

  1. Palmer, J P

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  2. Partke, H J

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

  3. Pauly, R P

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

  4. Pedersen, O

    • The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians. Diabetes August 1998 47:1359-1361

  5. Pederson, R A

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

  6. Peters, R K

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  7. Phillips, N E

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  8. Pianta, A

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  9. Piganelli, J D

    • Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes August 1998 47:1212-1218; doi:10.2337/diabetes.47.8.1212

  10. Polonsky, K S

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  11. Prins, J B

    • Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes August 1998 47:1365-1368; doi:10.2337/diabetes.47.8.1365

R

  1. Reifsnyder, P C

    • NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes August 1998 47:1287-1295; doi:10.2337/diabetes.47.8.1287

  2. Rosdahl, H

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  3. Rossini, A A

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  4. Rothenberg, P L

    • Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: evidence for autocrine beta-cell regulation. Diabetes August 1998 47:1243-1252; doi:10.2337/diabetes.47.8.1243

  5. Roth, R A

    • Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes August 1998 47:1281-1286; doi:10.2337/diabetes.47.8.1281

S

  1. Scharfmann, R

    • Fibroblast growth factor 2 promotes pancreatic epithelial cell proliferation via functional fibroblast growth factor receptors during embryonic life. Diabetes August 1998 47:1236-1242; doi:10.2337/diabetes.47.8.1236

  2. Schlenzig, D

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

  3. Sehlin, J

    • Lactate production in pancreatic islets. Diabetes August 1998 47:1219-1223; doi:10.2337/diabetes.47.8.1219

  4. Semplicini, A

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  5. Shinozaki, K

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  6. Sho, K

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  7. Shultz, L D

    • Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes August 1998 47:1199-1206; doi:10.2337/diabetes.47.8.1199

  8. Siddle, K

    • Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes August 1998 47:1365-1368; doi:10.2337/diabetes.47.8.1365

  9. Slaughter, M

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  10. Sochett, E B

    • Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes. Diabetes August 1998 47:1341-1346; doi:10.2337/diabetes.47.8.1341

  11. Soos, M A

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  12. Spoerri, P E

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311
    • Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes August 1998 47:1335-1340; doi:10.2337/diabetes.47.8.1335

  13. Sussel, L

    • Beta-cell transcription factors and diabetes: mutations in the coding region of the BETA2/NeuroD1 (NEUROD1) and Nkx2.2 (NKX2B) genes are not associated with maturity-onset diabetes of the young in Japanese. Diabetes August 1998 47:1356-1358; doi:10.2337/diabetes.47.8.1356

T

  1. Takeda, J

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  2. Takeuchi, T

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  3. Taki, H

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  4. Tamarit-Rodriguez, J

    • Lactate production in pancreatic islets. Diabetes August 1998 47:1219-1223; doi:10.2337/diabetes.47.8.1219

  5. Tarnuzzer, R W

    • Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes August 1998 47:1311-1317; doi:10.2337/diabetes.47.8.1311

  6. Tasic, V

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  7. Tengholm, A

    • In situ characterization of nonmitochondrial Ca2+ stores in individual pancreatic beta-cells. Diabetes August 1998 47:1224-1230; doi:10.2337/diabetes.47.8.1224

  8. Tiengo, A

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  9. Tomura, H

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  10. Toseland, C D

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  11. Trevisan, R

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

  12. Trigo, E

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  13. Turner, N C

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

U

  1. Ungerstedt, U

    • Effect of physiological hyperinsulinemia on blood flow and interstitial glucose concentration in human skeletal muscle and adipose tissue studied by microdialysis. Diabetes August 1998 47:1296-1301; doi:10.2337/diabetes.47.8.1296

  2. Urhammer, S A

    • The g/a nucleotide variant at position -30 in the beta-cell-specific glucokinase gene promoter has no impact on the beta-cell function in Danish Caucasians. Diabetes August 1998 47:1359-1361

V

  1. Vedovato, M

    • Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes August 1998 47:1347-1353; doi:10.2337/diabetes.47.8.1347

W

  1. Wallberg-Henriksson, H

    • Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes August 1998 47:1281-1286; doi:10.2337/diabetes.47.8.1281

  2. Wang, B

    • Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes August 1998 47:1207-1211; doi:10.2337/diabetes.47.8.1207

  3. Wank, U

    • Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes August 1998 47:1259-1265; doi:10.2337/diabetes.47.8.1259

  4. West, A

    • Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes August 1998 47:1326-1334; doi:10.2337/diabetes.47.8.1326

  5. White, H A

    • Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes August 1998 47:1253-1258; doi:10.2337/diabetes.47.8.1253

  6. Whitehead, J P

    • Multiple molecular mechanisms of insulin receptor dysfunction in a patient with Donohue syndrome. Diabetes August 1998 47:1362-1364; doi:10.2337/diabetes.47.8.1362

  7. Winder, W W

    • Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes August 1998 47:1369-1373; doi:10.2337/diabetes.47.8.1369

X

  1. Xiang, A

    • Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes August 1998 47:1302-1310; doi:10.2337/diabetes.47.8.1302

  2. Xu, G G

    • Insulin receptor signaling in the beta-cell influences insulin gene expression and insulin content: evidence for autocrine beta-cell regulation. Diabetes August 1998 47:1243-1252; doi:10.2337/diabetes.47.8.1243

Y

  1. Yamada, S

    • Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes August 1998 47:1354-1355; doi:10.2337/diabetes.47.8.1354

  2. Yamagata, K

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  3. Yamamoto, K

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  4. Yang, Q

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

  5. Yasuda, H

    • Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes August 1998 47:1318-1325; doi:10.2337/diabetes.47.8.1318

  6. Yoshiuchi, I

    • Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes August 1998 47:1231-1235; doi:10.2337/diabetes.47.8.1231

Z

  1. Zierath, J R

    • Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes August 1998 47:1281-1286; doi:10.2337/diabetes.47.8.1281

  2. Zorzano, A

    • Overexpression of glycogen phosphorylase increases GLUT4 expression and glucose transport in cultured skeletal human muscle. Diabetes August 1998 47:1185-1192; doi:10.2337/diabetes.47.8.1185

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement